Results 211 to 220 of about 2,239,923 (360)

Development of Digital Amnesia Scale Adolescent Form‐DAADF and Examination of Psychometric Characteristics

open access: yesJournal of Adolescence, EarlyView.
ABSTRACT Objective The aim of the study was to develop the “Digital Amnesia Scale Adolescent Form‐DAADF” to determine digital amnesia in adolescents aged 12–18 years and to examine its psychometric characteristics. Methods In the study, 625 adolescents between the ages of 12–18 who use digital devices such as smartphones/watches/tablets/computers ...
Elçin Babaoğlu   +3 more
wiley   +1 more source

Microsaccades Tracking by Secondary Speckle Pattern Analysis

open access: yesJournal of Biophotonics, EarlyView.
A new approach for detecting microsaccades is introduced using secondary speckle patterns reflected from the sclera. This method offers potential benefits in capturing subtle eye movements and overcoming limitations in traditional pupil‐tracking systems.
Ola Shteinberg   +6 more
wiley   +1 more source

Identification of Borderline Personality Disorder in Adolescents: Psychometric Properties and Diagnostic Efficiency of a Juvenile Version of the Impulsivity and Emotion Dysregulation Scale (IES‐27‐J)

open access: yesJournal of Clinical Psychology, EarlyView.
ABSTRACT Objective The diagnostic efficiency of screening instruments for adolescents with Borderline Personality Disorder (BPD)—that are applicable to its new classification in DSM‐5 and ICD‐11—has not yet been sufficiently studied. Methods We examined the reliability and diagnostic efficiency of the juvenile version of the Impulsivity and Emotion ...
Maria Brede   +4 more
wiley   +1 more source

Results of the ACTION‐Galactosemia Kids Study to Evaluate the Effects of Govorestat in Pediatric Patients with Classic Galactosemia

open access: yesThe Journal of Clinical Pharmacology, EarlyView.
Abstract To evaluate the pharmacodynamic effects and clinical outcomes of orally administered once‐daily govorestat (AT‐007), a central nervous system penetrant aldose reductase inhibitor, the double‐blind placebo‐controlled ACTION‐Galactosemia Kids study (NCT04902781) randomly assigned 47 participants (2–17 years old) with Classic Galactosemia to 18 ...
Evan Bailey   +17 more
wiley   +1 more source

Home - About - Disclaimer - Privacy